Paul Robert 4

Accession 0001209191-21-046034

CIK 0001653087other

View on SEC.gov Company Profile

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 6:24 PM ET

Size

35.2 KB

Accession

0001209191-21-046034

Insider Transaction Report

Form 4

Period: 2021-07-06

Alector, Inc.ALEC

Paul Robert

Chief Medical Officer

Transactions

Sale
Common Stock
2021-07-06$37.43/sh−1,000$37,434→ 249,495 total
Sale
Common Stock
2021-07-06$39.20/sh−10,495$411,411→ 235,419 total
Sale
Common Stock
2021-07-07$38.14/sh−7,700$293,686→ 251,468 total
Sale
Common Stock
2021-07-06$35.10/sh−10,224$358,813→ 254,095 total
Sale
Common Stock
2021-07-06$40.01/sh−1,100$44,016→ 234,319 total
Exercise/Conversion
Common Stock
2021-07-07$8.16/sh+7,292$59,503→ 241,611 total
Exercise/Conversion
Common Stock
2021-07-07$10.14/sh+11,883$120,494→ 253,494 total
Sale
Common Stock
2021-07-06$38.55/sh−3,581$138,059→ 245,914 total
Exercise/Conversion
Employee Stock Option (right to buy)
2021-07-07−7,292→ 90,691 total
Exercise: $8.16Exp: 2028-07-02→ Common Stock (7,292 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2021-07-07−10,574→ 88,975 total
Exercise: $17.15Exp: 2029-11-06→ Common Stock (10,574 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2021-07-06−30,000→ 99,549 total
Exercise: $17.15Exp: 2029-11-06→ Common Stock (30,000 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2021-07-07−11,883→ 39,984 total
Exercise: $10.14Exp: 2028-11-06→ Common Stock (11,883 underlying)
Exercise/Conversion
Common Stock
2021-07-06$17.15/sh+30,000$514,500→ 264,319 total
Sale
Common Stock
2021-07-06$35.95/sh−3,600$129,433→ 250,495 total
Exercise/Conversion
Common Stock
2021-07-07$17.15/sh+10,574$181,344→ 264,068 total
Sale
Common Stock
2021-07-07$37.41/sh−4,900$183,332→ 259,168 total
Sale
Common Stock
2021-07-07$39.32/sh−17,149$674,220→ 234,319 total

Footnotes (13)

[F1]The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020.
[F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.95 to $39.62, inclusive.
[F11]Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019.
[F12]Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018.
[F13]One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.65 to $35.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (10) to this Form 4.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.66 to $36.64, inclusive.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.80 to $37.78, inclusive.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.81 to $38.79, inclusive.
[F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.81 to $39.79, inclusive.
[F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.91 to $40.16, inclusive.
[F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.70 to $37.69, inclusive.
[F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $38.54, inclusive.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Alector, Inc.

CIK 0001653087

→

Entity typeother

Related Parties

filerCIK 0001757964

Filing Metadata

Form type: 4
Filed: Jul 7, 8:00 PM ET
Accepted: Jul 8, 6:24 PM ET
Size: 35.2 KB

View on SEC.gov